ArticleFrontiers in pharmacology2018

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML.

Daniel Heudobler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.